ChloraPrep — a proven system for patient preoperative skin preparation
ChloraPrep applicators help improve patient outcomes by reducing skin microorganisms that can cause bloodstream infections (BSIs) and surgical site infections (SSIs). The 2% CHG/70% IPA formulation and single-use applicators provide a proven system for infection control compliance across major and minor procedures.
Formulation
ChloraPrep is a combination of 2% chlorhexidine gluconate (CHG) and 70% isopropyl alcohol (IPA).
ChloraPrep provides two distinct mechanisms of action:
Device
The ChloraPrep advantage versus traditional iodophors
ChloraPrep provides superior, rapid-acting, persistent, and broad-spectrum antisepsis compared to traditional iodophors.
Clinical evidence
When used with other CDC-recommended interventions, ChloraPrep reduced catheter-related BSIs by 89.3% in a Brookdale University Medical Center Clinical Study8. And, in a clinical study that compared two other surgical preparation solutions to ChloraPrep, the study determined that ChloraPrep was the most efficacious for eliminating bacteria from the hallux and toe sites (P<0.0001).9
The following studies demonstrate the superiority of ChloraPrep as a patient preoperative skin preparation:
Additional clinical studies supporting 2% CHG and CHG formulations
Review more than 30 clinical studies that support the efficacy of 2% chlorhexidine and chlorhexidine-based solutions as superior patient preoperative skin preparation antiseptics.
DuraPrep is a trademark of 3M Health Care; Techni-Care is a registered trademark of Care-Tech Laboratories, Inc.
1 Brown E, Wenzel RP, Hendley JO. Exploration of the microbial anatomy of normal human skin by using plasmid profiles of coagulase-negative staphylococci: search for the reservoir of resident skin flora. J Infect Dis. 1989;160:644–650.
2 Crosby CT , Mares AK. Skin antisepsis: past, present, and future. J Vasc Access Devices. Spring 2001:26-31.
3 Garcia R, Mulberry G, Brady A, Hibbard JS. Comparison of ChloraPrep and Betadine as preoperative skin preparation antiseptics. Poster presented at: 40th Annual Meeting of the Infectious Disease Society of America; October 25, 2002.
4 Data on file. Enturia, Inc.
5 Denton GW. Chlorhexidine. In: Block SS. Disinfection, Sterilization, and Preservation. 5th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001:321-336.
6 Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular cather-site care: a meta-analysis. Ann Intern Med. 2002; 136: 792-801.
7 Gottardi W. Iodine and Iodine Compounds. In: Block SS. Disinfection, Serilization, and Preservation. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:159-183.
8 Garcia R, Jendresky L, Landesman S, Maher A, Nicolas F. Three years experience in implementing HICPAC recommendations for the reduction of central venous catheter-related bloodstream infections. Manag Infect Control. 2003;10:42-49.
9 Ostrander RV, Botte MJ, Brage ME. Efficacy of surgical preparation solutions in foot and ankle surgery. J Bone Joint Surg Am. 2005;87:980-985.
Call with questions.
Monday – Thursday
7 a.m. to 5 p.m. CST
Friday
7 a.m. to 1 p.m. CST
Information contained on this site pertains only to the United States of America.